Skip to main content

Erleada and Alcohol/Food Interactions

There are 2 alcohol/food/lifestyle interactions with Erleada (apalutamide).

Moderate

Apalutamide High Blood Pressure (Hypertension)

Moderate Potential Hazard, Moderate plausibility

apalutamide - CV events

Ischemic cardiovascular events, including events leading to death, occurred in patients receiving apalutamide. It is recommended to monitor for signs and symptoms of ischemic heart disease and to consider discontinuation of treatment for Grade 3 and 4 events. Care should be exercised when prescribing this agent in patients at risk of an ischemic cardiovascular event, such as in those patients with hypertension, diabetes, or dyslipidemia.

References

  1. (2018) "Product Information. Erleada (apalutamide)." Janssen Biotech, Inc.
Moderate

Apalutamide High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)

Moderate Potential Hazard, Moderate plausibility

apalutamide - CV events

Ischemic cardiovascular events, including events leading to death, occurred in patients receiving apalutamide. It is recommended to monitor for signs and symptoms of ischemic heart disease and to consider discontinuation of treatment for Grade 3 and 4 events. Care should be exercised when prescribing this agent in patients at risk of an ischemic cardiovascular event, such as in those patients with hypertension, diabetes, or dyslipidemia.

References

  1. (2018) "Product Information. Erleada (apalutamide)." Janssen Biotech, Inc.

Erleada drug interactions

There are 610 drug interactions with Erleada (apalutamide).

Erleada disease interactions

There are 5 disease interactions with Erleada (apalutamide) which include:

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer